Controlled release of small molecules from silica xerogel with limited nanoporosity

Journal of Materials Science: Materials in Medicine

Volumn 24, Issue 1, 2013, Pages 137-146

  Chen, Rong ^a,b   Qu, Haibo ^a   Agrawal, Ashwin ^a   Guo, Shaoyun ^b   Ducheyne, Paul ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; CEPHALEXIN; CONTROLLED RELEASE; DRYING STEP; FORMATION MECHANISM; GLASSY SOLIDS; HIGUCHI MODEL; NANOPOROSITY; RELEASE KINETICS; RELEASE MECHANISM; SILICA XEROGEL; SMALL MOLECULES; SOL-GEL MATERIALS; SOL-GEL PROCESSING; SOL-GEL SYNTHESIS; SOL-GEL SYSTEMS; SYNTHESIS PARAMETERS; VANCOMYCIN;

CONDENSATION; HYDROLYSIS; MOLECULES; SILICA GEL; SOL-GEL PROCESS; SOL-GELS; XEROGELS;

CASTING;

BUPIVACAINE; CEFALEXIN; SILICON DIOXIDE; VANCOMYCIN;

ACCELERATION; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED DRUG RELEASE; IN VITRO STUDY; ISOELECTRIC POINT; MELTING POINT; MOLECULAR WEIGHT; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; SURFACE PROPERTY; TEMPERATURE;

ANTI-BACTERIAL AGENTS; BUPIVACAINE; CEPHALEXIN; GELS; HYDROLYSIS; NANOTECHNOLOGY; SILICON DIOXIDE; VANCOMYCIN;

EID: 84872416461     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-012-4783-3     Document Type: Article

References (35)

1. Ducheyne P, Qiu QQ. Bioactive ceramics: the effect of surface reactivity on bone formation and bone cell function. Biomaterials. 1999;20:2287-303.
2. Li ZZ, Wen LX, Shao L, Chen JF. Fabrication of porous hollow silica nanoparticles and their applications in drug release control. J Control Release. 2004;98:245-54.
3. Maver U, Godec A, Bele M, Planinsek O, Gaberscek M, Srcic S, Jamnik J. Novel hybrid silica xerogels for stabilization and controlled release of drug. Int J Pharmaceut. 2007;330:164-74.
4. Quintanar-Guerrero D, Ganem-Quintanar A, Nava-Arzaluz MG, Piñón-Segundo E. Silica xerogels as pharmaceutical drug carriers. Expert Opin Drug Del. 2009;6:485-98.
5. Slowing II, Vivero-Escoto JL, Wu C-W, Lin VS-Y. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliver Rev. 2008;60:1278-88.
6. Radin S, Chen T, Ducheyne P. The controlled release of drugs from emulsified, sol gel processed silica microspheres. Biomaterials. 2009;30:850-8.
7. Park HS, Kim CW, Lee HJ, Choi JH, Lee SG, Yun YP, Kwon IC, Lee SJ, Jeong SY, Lee SC. A mesoporous silica nanoparticles with charge-convertible pore walls for efficient intracellular protein delivery. Nanotechnology. 2010;21:1-9.
8. Nicoll SB, Radin S, Santos EM, Tuan RS, Ducheyne P. In vitro release kinetics of biologically active transforming growth factor-β1 from a novel porous glass carrier. Biomaterials. 1997;18:853-9.
9. Santos EM, Radin S, Ducheyne P. Sol-gel derived carrier for the controlled release of proteins. Biomaterials. 1999;20:1695-700.
10. Falaize S, Radin S, Ducheyne P. In vitro behavior of silica-based xerogels intended as controlled release carriers. J Am Ceram Soc. 1999;82:969-76.
11. Radin S, Ducheyne P, Kamplain T, Tan B. Silica sol-gel for the controlled release of antibiotics I. Synthesis, characterization, and in vitro release. J Biomed Mater Res. 2001;57:313-20.
12. Yao J, Radin S, Leboy PS, Ducheyne P. The effect of bioactive glass content on synthesis and bioactivity of composite poly(lactic-co-glylic acid)/bioactive glass substrate for tissue engineering. Biomaterials. 2005;26:1935-43.
13. Prokopowicz M. Silica-polyethylene glycol matrix synthesis by sol-gel method and evaluation for diclofenac diethyloammonium release. Drug Deliv. 2007;14:129-38.
14. Costache MC, Qu H, Ducheyne P, Devore DI. Polymer-xerogel composites for controlled release wound dressings. Biomaterials. 2010;31:6336-43.
15. Czarnobaj K. Sol-gel-processed silica/polydimethylsiloxane/calcium xerogels as polymeric matrices for metronidazole delivery system. Polym Bull. 2010;66:223-37.
16. Prokopowicz M. In vitro controlled release of doxorubicin from silica xerogels. J Pharm Pharmacol. 2010;59:1365-73.
17. Radin S, Ducheyne P. Nanostructural control of implantable xerogels for the controlled release of biomolecules. In: Reis RL, Weiner S, editors. Learning from nature how to design new implantable materials: from biomineralization fundamentals to biomimetic materials and processing routes. Netherland: Kluwer Academic Publishers; 2004. p. 59-74.
18. Aughenbaugh W, Radin S, Ducheyne P. Silica sol gel for the controlled release of antibiotics II. The effect of synthesis parameters on the in vitro release kinetics of vancomycin. J Biomed Mater Res. 2001;57:321-6.
19. Roveri N, Morpurgo M, Palazzo B, Parma B. Vivi L. Silica xerogels as a delivery system for the controlled release of different molecular weight heparins. Anal Bioanal Chem. 2005;381:601-6.
20. Böttcher H, Slowik P, Süß W. Sol-gel carrier systems for controlled drug delivery. J Sol-Gel Sci Technol. 1998;13:277-81.
21. Kortesuo P, Ahola M, Kangas M, Leino T, Laakso S, Vuorilehto L. Alkyl-substituted silica gel as a carrier in the controlled release of dexmedetomidine. J Control Release. 2001;76:227-38.
22. Xue JM, Shi M. PLGA/mesoporous silica hybrid structure for controlled drug release. J Control Release. 2004;98:209-17.
23. Xue JM, Tan CH, Lukito D. Biodegradable polymer-silica xerogel composite microspheres for controlled release of gentamicin. J Biomed Mater Res B. 2006;78B:417-22.
24. Wen LX, Li ZZ, Zou HK, Liu AQ, Chen JF. Controlled release of avermectin from porous hollow silica nanoparticles. Pest Manag Sci. 2005;61:583-90.
25. Tan S, Wu Q, Wang J, Wang Y, Liu X, Sui K, Deng X, Wang H, Wu M. Dynamic self-assembly synthesis and controlled release as drug vehicles of porous hollow silica nanoparticles. Micropor Mesopor Mat. 2011;142:601-8.
26. Jiang X, Liu N, Assink RA, Jiang Y, Brinker CJ. Photoresponsive release from azobenzene-modified single cubic crystal NaCl/silica particles. J Nanomater. 2011;2011:1-6.
27. Xu W, Gao Q, Xu Y, Wu D, Sun Y, Shen W, Deng F. Controllable release of ibuprofen from size-adjustable and surface hydrophobic mesoporous silica spheres. Powder Technol. 2009;191:13-20.
28. Ackerman BH, Buono FAD. In vitro testing of antibiotics. Pharmacotherpy. 1996;16:201-17.
29. Ahola MS, Sailynoja ES, Raitavuo MH, Vaahtio MM, Salonen JI, Yli-Urpo AUO. In vitro release of heparin from silica xerogels. Biomaterials. 2001;22:2163-70.
30. Barbé C, Bartlett J, Kong L, Finnie K, Lin HQ, Larkin M, Calleja S, Bush A, Calleja G. Silica particles: a novel drug-delivery system. Adv Mater. 2004;16:1959-66.
31. Basaldella EI, Legnoverde MS. Functionalized silica matrices for controlled delivery of cephalexin. J Sol-Gel Sci Technol. 2010;56:191-6.
32. Hatanaka T, Morigaki S, Aiba T, Katayama K, Koizumi T. Effect of pH on the skin permeability of a zwitterionic drug, cephalexin. Int J Pharmaceut. 1995;125:195-203.
33. Saravanan M, Nataraj KS, Ganesh KS. Hydroxypropyl methylcellulose based cephalexin extended release tablets: Influence of tablet formulation, hardness and storage on in vitro release kinetics. Chem Pharm Bull. 2003;51:978-83.
34. Kortesuo P, Ahola M, Kangas M, Kangasniemi I, Yli-Urpo A, Kiesvaara J. In vitro evaluation of sol-gel processed spray dried silica gel microspheres as carrier in controlled drug delivery. Int J Pharmaceut. 2000;200:223-9.
35. Kortesuo P, Ahola M, Kangas M, Jokinen M, Leino T, Vuorilehto L, Laakso S, Kiesvaara J, Yli-Urpp A, Marvola M. Effect of synthesis parameters of the sol-gel-processed spray-dried silica gel microparticles on the release rate of dexmedetomidine. Biomaterials. 2002;23:2795-801.